Alberico L. Catapano
University of Milan
740 Papers
5.6K Citations
Alberico L. Catapano is an academic researcher from University of Milan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 89, co-authored 630 publications. Previous affiliations of Alberico L. Catapano include European Society of Cardiology & Baylor College of Medicine.
Chat about Author
Papers
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.
TL;DR: In this article, HDL-C levels and HDL composition are altered in patients with autoimmune diseases and usually associated with disease severity, and the contribution of HDL beyond cholesterol efflux is elucidated.
51
Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Dong Keon Yon,Se Yong Jung,Seo-Yeon Park,Benjamin A Stark,Christian Razo,Mohammadreza Abbasian,Hedayat Abbastabar,Amir Parsa Abhari,Victor Aboyans,Denberu Eshetie Adane,Oladimeji Adebayo,F Alahdab,Sami Almustanyir,Hany M. Aly,Edward Kwabena Ameyaw,Jason A. Anderson,Catalina Liliana Andrei,Zahra Aryan,Avinash Aujayeb,S. Bagherieh,Ovidiu Baltatu,Maciej Banach,N. S. Bayileyegn,Lindsay M Bearne,Amir Hossein Behnoush,Isabela M. Benseñor,Sonu Bhaskar,Ajay N Bhat,Vivek Bhat,Boris Bikbov,Bagas Suryo Bintoro,Katrin Burkart,L.A. Cámera,Alberico L. Catapano,E. Chandrasekar,Jaykaran Charan,Vijay Kumar Chattu,Gerald Chi,I. S. Chukwu,Massimo Cirillo,Kaleb Coberly,Vera Marisa Costa,Omid Dadras,Xiaochen Dai,Thanh Chi Do,Rajkumar Doshi,Michael Ekholuenetale,Islam Y. Elgendy,Muhammed Elhadi,Adeniyi Francis Fagbamigbe,Alireza Feizkhah,Ginenus Fekadu,Paramjit S Gill,Mohamad Goldust,Mahaveer Golechha,Shi-Yang Guan,Vivek K. Gupta,Mostafa Hadei,Najah R. Hadi,Ahmad Hammoud,Graeme J. Hankey,Netanja I. Harlianto,Ahmed I. Hasaballah,Shoaib bin Hassan,Mohammed Bheser Hassen,Golnaz Heidari,Mihaela Hostiuc,Olayinka Stephen Ilesanmi,Masao Iwagami,Mohammad Hassan Jokar,Jost B. Jonas,Charity Ehimwenma Joshua,Jacek Jerzy Jozwiak,Sina Kazemian,Mohammad Keykhaei,A. Khalaji,Sorour Khateri,Biruk Getahun Kibret,Oleksii Korzh,Sindhura Lakshmi Koulmane Laxminarayana,Kewal Krishan,Akshay Kumar,Rajesh Kumar,A. Kuttikkattu,Tri Laksono,Bagher Larijani,Stephen S Lim,Xuefeng Liu,Stefan Lorkowski,Hassan Magdy Abd El Razek,Kashish Malhotra,Yosef Manla,A. Maugeri,Alexios-Fotios A. Mentis,Tomislav Mestrovic,Ana Carolina Micheletti Gomide Nogueira de Sá,Andreea Mirică,Erkin M. Mirrakhimov,Awoke Misganaw,Manish Mishra,Yousef Mohammad,A. H. Mokdad,Mohammad Ali Moni,Ahmed Al Montasir,Yousef Moradi,Paula Moraga,Negar Morovatdar,Seyed Ali Mousavi-Aghdas,Christopher J L Murray,Mohsen Naghavi,Tapas Sadasivan Nair,H. Nassereldine,Zuhair S. Natto,Dang H. Nguyen,Van Thanh Nguyen,Jean Jacques Noubiap,Bogdan Oancea,Gláucia M.M. Oliveira,Mayowa O. Owolabi,Alicia Padron-Monedero,Norberto Perico,Ionela-Roxana Petcu,Amir Radfar,Quinn Rafferty,Mosiur Rahman,Muhammad Aziz Rahman,Pradhum Ram,Sina Rashedi,Ahmed Mustafa Rashid,Salman Rawaf,Giuseppe Remuzzi,Andre M. N. Renzaho,M. Rezaee,Leonardo Roever,AlYahya Mohammed Saad,Seyedmohammad Saadatagah,Masoumeh Sadeghi,Amirhossein Sahebkar,Mohamed A. Saleh,Abdallah M. Samy,Milena M. Santric-Milicevic,Sadaf G. Sepanlou,Allen Seylani,Sadaf Sharfaei,Seyed Afshin Shorofi,Paramdeep Singh,Michael Spartalis,Johan Sundström,Masayuki Teramoto,Samar Tharwat,Stefanos Tyrovolas,Sahel Valadan Tahbaz,Jef Van den Eynde,Priya Vart,Cong Wang,Ronny Westerman,Suowen Xu,Dereje Y. Yada,Kazumasa Yamagishi,Naohiro Yonemoto,Mazyar Zahir,Moein Zangiabadian,Armin Zarrintan,Mikhail Sergeevich Zastrozhin,Anasthasia Zastrozhina,M. Zoladl,Simon I. Hay,Gregory A. Roth +167 more
TL;DR: The total number of people with peripheral artery disease has increased globally from 1990 to 2019, and despite the lower prevalence in males and low-income countries, these groups showed similar DALY rates to females and higher- Income countries, highlighting disproportionate burden in these groups.
51
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis
Kamal Awad,Dimitri P. Mikhailidis,Peter P. Toth,Steven R. Jones,Patrick M. Moriarty,Gregory Y.H. Lip,Paul Muntner,Alberico L. Catapano,Michael J. Pencina,Robert S. Rosenson,Jacek Rysz,Maciej Banach,Maciej Banach +12 more
TL;DR: Alternate-day dosing of individual statins (especially atorvastatin and rosuvastsatin) is as efficacious as daily dosing on LDL-C and TG.
50
Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
TL;DR: A meta-analysis of data from 14 randomized, double-blind clinical trials that compared the effectiveness of two new options for cholesterol lowering suggested greater LDL-C lowering with ezetimibe/simVastatin compared with rosuvastatin.
49
Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
TL;DR: Modulation of gene expression in the endothelium should be taken into account when studying the effects of LXR and RXR agonists on lipid metabolism in the arterial wall.
48